SavedAdd your journal

Journals / Cukurova Medical Journal / 2019 / Cilt: 44 - Sayı: 2

WHO treatment guidelines against leprosy: a focus on pharmacovigilance.

DSÖ lepra tedavi kılavuzu: farmakovijilansa odaklanma

Pugazhenthan THANGARAJU
Sajitha VENKATESAN
Pages
701–702
Publication Date
2019-06-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗

Abstract

A focus on Pharmacovigilance

Özet

-

🔖

Cite This Article

THANGARAJU, P., VENKATESAN, S. (2019). WHO treatment guidelines against leprosy: a focus on pharmacovigilance.. Cukurova Medical Journal, Cilt: 44 - Sayı: 2, 701–702. https://ajindex.com/articles/116932

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. WHO. Guidelines for the Diagnosis, Treatment and Prevention of Leprosy.New Delhi, WHO, 2018
  2. WHO. Pharmacovigilance. https: //www.who.int /medicines/ areas/quality_safety/ safety_efficacy/pharmvigi/en/. Accessed on 11/01/2019
  3. Thangaraju P, Venkatesan S, Tamilselvan T, Sivashanmugam E, Showkath Ali M K. Evaluation of awareness about pharmacovigilance and adverse drug reaction monitoring among medical professionals attending Central Leprosy Institute. Mustansiriya Med J 2018;17:63-8.